Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.53 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 6/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15750053 | 0.98 | MEN1 (0.54) | MEN1KMT2AENPP3ADORA2AADORA1 | |
| SCHEMBL4401758 | 0.96 | MEN1 (0.54) | MEN1KMT2AENPP3ADORA2AADORA1 | |
| SCHEMBL4546955 | 0.96 | MEN1 (0.53) | MEN1KMT2AENPP3ADORA2AADORA1 | |
| SCHEMBL4546873 | 0.96 | MEN1 (0.53) | MEN1KMT2AENPP3ADORA2AADORA1 | |
| SCHEMBL13203169 | 0.94 | MEN1 (0.51) | MEN1KMT2AENPP3ADORA2AADORA1 | |
| SCHEMBL16373506 | 0.94 | MEN1 (0.60) | MEN1KMT2AENPP3ADORA2AADORA1 | |
| SCHEMBL4546988 | 0.94 | MEN1 (0.51) | MEN1KMT2AENPP3ADORA2AADORA1 | |
| SCHEMBL4546876 | 0.94 | MEN1 (0.60) | MEN1KMT2AENPP3ADORA2AADORA1 | |
| SCHEMBL13203163 | 0.94 | MEN1 (0.51) | MEN1KMT2AENPP3ADORA2AADORA1 | |
| SCHEMBL4404679 | 0.94 | MEN1 (0.51) | MEN1KMT2AENPP3ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8877355-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-11-04 | — | — | US | disclosed |
| US-20130214263-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-08-22 | — | — | US | disclosed |
| US-8427046-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8168307-B2 | Organic compound, charge transport material and organic electroluminescent device | PIONEER CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | PIONEER CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC25A21, SLCO2A1, OCIAD2 | MEN1 1827/4885KMT2A 1162/4885ENPP3 3963/4885 |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | NFE2L2, SLC19A2, AOC2 | MEN1 3718/4885KMT2A 2140/4885ENPP3 2782/4885 |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC7A5, SLC18A1, MAOA | MEN1 2206/4885KMT2A 982/4885ENPP3 3276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.